Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Peer-led and professional-led group interventions for people with co-occurring disorders: a qualitative study.

Pallaveshi L, Balachandra K, Subramanian P, Rudnick A.

Community Ment Health J. 2014 May;50(4):388-94. doi: 10.1007/s10597-013-9612-8. Epub 2013 Aug 13.

PMID:
23943019
2.

Homelessness and mental illness in a professional- and peer-led cocaine treatment clinic.

Galanter M, Dermatis H, Egelko S, De Leon G.

Psychiatr Serv. 1998 Apr;49(4):533-5.

PMID:
9550249
3.

First-Person Perspectives on Dual Diagnosis Anonymous (DDA): A Qualitative Study.

Roush S, Monica C, Carpenter-Song E, Drake RE.

J Dual Diagn. 2015;11(2):136-41. doi: 10.1080/15504263.2015.1025215.

PMID:
25781586
4.

Gender differences in treatment retention among individuals with co-occurring substance abuse and mental health disorders.

Choi S, Adams SM, Morse SA, MacMaster S.

Subst Use Misuse. 2015 Apr;50(5):653-63. doi: 10.3109/10826084.2014.997828. Epub 2015 Jan 14.

PMID:
25587672
5.

Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment.

Baker KD, Lubman DI, Cosgrave EM, Killackey EJ, Yuen HP, Hides L, Baksheev GN, Buckby JA, Yung AR.

Aust N Z J Psychiatry. 2007 Nov;41(11):896-902.

PMID:
17924242
6.

Peer-led seeking safety: results of a pilot outcome study with relevance to public health.

Najavits LM, Hamilton N, Miller N, Griffin J, Welsh T, Vargo M.

J Psychoactive Drugs. 2014 Oct-Dec;46(4):295-302. doi: 10.1080/02791072.2014.922227.

PMID:
25188699
7.

The recovery group project: development of an intervention led jointly by peer and professional counselors.

Green CA, Janoff SL, Yarborough BJ, Paulson RI.

Psychiatr Serv. 2013 Dec 1;64(12):1211-7. doi: 10.1176/appi.ps.201200546.

PMID:
23999845
8.

Interventions for drug-using offenders with co-occurring mental illness.

Perry AE, Neilson M, Martyn-St James M, Glanville JM, Woodhouse R, Godfrey C, Hewitt C.

Cochrane Database Syst Rev. 2015 Jun 2;(6):CD010901. doi: 10.1002/14651858.CD010901.pub2. Review.

PMID:
26034938
9.

Interventions for drug-using offenders with co-occurring mental illness.

Perry AE, Neilson M, Martyn-St James M, Glanville JM, McCool R, Duffy S, Godfrey C, Hewitt C.

Cochrane Database Syst Rev. 2014 Jan 2;(1):CD010901. doi: 10.1002/14651858.CD010901. Review. Update in: Cochrane Database Syst Rev. 2015;(6):CD010901.

PMID:
24385324
10.

Contingency management for patients with dual disorders in intensive outpatient treatment for addiction.

Kelly TM, Daley DC, Douaihy AB.

J Dual Diagn. 2014;10(3):108-17. doi: 10.1080/15504263.2014.924772.

11.

Dual recovery among people with serious mental illnesses and substance problems: a qualitative analysis.

Green CA, Yarborough MT, Polen MR, Janoff SL, Yarborough BJ.

J Dual Diagn. 2015;11(1):33-41. doi: 10.1080/15504263.2014.975004. Epub 2014 Dec 9.

12.

Feasibility of Behavioral Weight Loss Treatment Enhanced with Peer Support and Mobile Health Technology for Individuals with Serious Mental Illness.

Aschbrenner KA, Naslund JA, Shevenell M, Mueser KT, Bartels SJ.

Psychiatr Q. 2016 Sep;87(3):401-15. doi: 10.1007/s11126-015-9395-x.

13.

Integrating Permanent Supportive Housing and Co-Occurring Disorders Treatment for Individuals Who Are Homeless.

Smelson DA, Zaykowski H, Guevermont N, Siegfriedt J, Sawh L, Modzelewski D, Tsemberis S, Kane V.

J Dual Diagn. 2016 Apr-Jun;12(2):193-201. doi: 10.1080/15504263.2016.1174010. Epub 2016 Apr 11.

PMID:
27064939
14.

Utilization of mental health and substance abuse care for people living with HIV/AIDS, chronic mental illness, and substance abuse disorders.

Weaver MR, Conover CJ, Proescholdbell RJ, Arno PS, Ang A, Ettner SL; Cost Subcommittee of the HIV/AIDS Treatment Adherence, Health Outcomes, and Cost Study Group.

J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):449-58. doi: 10.1097/QAI.0b013e3181642244.

PMID:
18197121
15.

Psychotherapies for adolescent substance abusers: a pilot study.

Kaminer Y, Burleson JA, Blitz C, Sussman J, Rounsaville BJ.

J Nerv Ment Dis. 1998 Nov;186(11):684-90.

PMID:
9824170
16.

Domains and perceived benefits of treatment among patients with and without co-occurring disorders in inpatient substance use treatment.

Bergly TH, Gråwe RW, Hagen R.

J Dual Diagn. 2014;10(2):91-7. doi: 10.1080/15504263.2014.906134.

PMID:
25392251
17.
18.

Enhancing health-care workers' understanding and thinking about people living with co-occurring mental health and substance use issues through consumer-led training.

Roussy V, Thomacos N, Rudd A, Crockett B.

Health Expect. 2015 Oct;18(5):1567-81. doi: 10.1111/hex.12146. Epub 2013 Oct 10.

19.

Peer workers' role in smoking-cessation groups for people with mental illness.

Ashton M, Mulconray S, Weston M, Rigby A, Galletly C.

Australas Psychiatry. 2013 Jun;21(3):246-8. doi: 10.1177/1039856212466924. Epub 2012 Nov 14.

PMID:
23152359
20.

Integrated versus parallel treatment of co-occurring psychiatric and substance use disorders.

Mangrum LF, Spence RT, Lopez M.

J Subst Abuse Treat. 2006 Jan;30(1):79-84.

PMID:
16377455

Supplemental Content

Support Center